These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7688878)

  • 1. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.
    Page RD; Sambrook MA; Crossman AR
    Neuroscience; 1993 Jul; 55(1):147-65. PubMed ID: 7688878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of thalamotomy in the treatment of levodopa-induced dyskinesia.
    Page RD
    Acta Neurochir (Wien); 1992; 114(3-4):77-117. PubMed ID: 1580197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.
    Mitchell IJ; Boyce S; Sambrook MA; Crossman AR
    Brain; 1992 Jun; 115 ( Pt 3)():809-24. PubMed ID: 1628204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of chorea and dystonia in parkinsonian primates.
    Boyce S; Clarke CE; Luquin R; Peggs D; Robertson RG; Mitchell IJ; Sambrook MA; Crossman AR
    Mov Disord; 1990; 5(1):3-7. PubMed ID: 2296255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalamic distribution of projection neurons to the primary motor cortex relative to afferent terminal fields from the globus pallidus in the macaque monkey.
    Inase M; Tanji J
    J Comp Neurol; 1995 Mar; 353(3):415-26. PubMed ID: 7538516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Mitchell IJ; Clarke CE; Boyce S; Robertson RG; Peggs D; Sambrook MA; Crossman AR
    Neuroscience; 1989; 32(1):213-26. PubMed ID: 2586750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.
    Fox SH; Henry B; Hill MP; Peggs D; Crossman AR; Brotchie JM
    Mov Disord; 2001 Jul; 16(4):642-50. PubMed ID: 11481687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projections from the globus pallidus to the thalamic areas projecting to the dorsal area 6 of the macaque monkey: a multiple tracing study.
    Inase M; Tanji J
    Neurosci Lett; 1994 Oct; 180(2):135-7. PubMed ID: 7535405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pallidal inputs to thalamocortical neurons projecting to the supplementary motor area: an anterograde and retrograde double labeling study in the macaque monkey.
    Tokuno H; Kimura M; Tanji J
    Exp Brain Res; 1992; 90(3):635-8. PubMed ID: 1385203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
    Calon F; Goulet M; Blanchet PJ; Martel JC; Piercey MF; Bédard PJ; Di Paolo T
    Brain Res; 1995 May; 680(1-2):43-52. PubMed ID: 7663983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey.
    Crossman AR; Peggs D; Boyce S; Luquin MR; Sambrook MA
    Neuropharmacology; 1989 Nov; 28(11):1271-3. PubMed ID: 2687716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Clarke CE; Sambrook MA; Mitchell IJ; Crossman AR
    J Neurol Sci; 1987 May; 78(3):273-80. PubMed ID: 3495642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque.
    Bezard E; Hill MP; Crossman AR; Brotchie JM; Michel A; Grimée R; Klitgaard H
    Eur J Pharmacol; 2004 Feb; 485(1-3):159-64. PubMed ID: 14757136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey.
    Crossman AR; Mitchell IJ; Sambrook MA
    Neuropharmacology; 1985 Jun; 24(6):587-91. PubMed ID: 3875056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Clarke CE; Boyce S; Robertson RG; Sambrook MA; Crossman AR
    J Neurol Sci; 1989 May; 90(3):307-14. PubMed ID: 2786926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.
    Mitchell IJ; Luquin R; Boyce S; Clarke CE; Robertson RG; Sambrook MA; Crossman AR
    Mov Disord; 1990; 5(1):49-54. PubMed ID: 2296259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
    Johnston TH; Fox SH; McIldowie MJ; Piggott MJ; Brotchie JM
    J Pharmacol Exp Ther; 2010 Jun; 333(3):865-73. PubMed ID: 20231306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia.
    Zeng BY; Iravani MM; Jackson MJ; Rose S; Parent A; Jenner P
    Neurobiol Dis; 2010 Dec; 40(3):599-607. PubMed ID: 20713157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa-induced dyskinesia and thalamotomy.
    Narabayashi H; Yokochi F; Nakajima Y
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):831-9. PubMed ID: 6381653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.